Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Rodney P Swartz
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 15 Dec, 2021
"Remove inverse infobox"
Golden AI
edited on 15 Dec, 2021
Edits made to:
Infobox
(
-236
properties)
Infobox
Patent primary examiner of
US Patent 11168326 Engineered immunostimulatory bacterial strains and uses thereof
US Patent 7087213 Method of preparing cow brain homogenate
US Patent 7090980 Method of detecting acid-fast bacteria using ribosomal RNA as target
US Patent 7094391 Compositions and methods for administering
US Patent 7094403 None
US Patent 7097845 Combinations of antigen and mucosal binding component for inducing specific immunological tolerance
US Patent 7105170 Latent human tuberculosis model, diagnostic antigens, and methods of use
US Patent 7115361 Detection of CD8+ T cell responses to
US Patent 7122195 Mutant mycobacteria for use in therapy
US Patent 7122196 Compounds and methods for diagnosis of tuberculosis
US Patent 11173193 Immunobiological products
US Patent 7135176 VMP-like sequences of pathogenic
US Patent 7135280 Assay to determine efficacy of treatment for mycobacterial infection
US Patent 7138121 Biosensors utilizing dendrimer-immobilized ligands and there use thereof
US Patent 7160548 None
US Patent 7163682 Glucan binding protein and glucosyltransferase immunogens
US Patent 7163798 Method of preparing cow brain homogenate
US Patent 7166270 Methods of screening compounds useful for prevention of infection or pathogenicity
US Patent 7172750 Compositions and methods for the treatment and diagnosis of immune disorders
US Patent 7179448 Recombinant constructs of
US Patent 7179467 DCMP2 polypeptide
US Patent 7186412 Fusion proteins of
US Patent 7189404 Strain selection of pneumococcal surface proteins
US Patent 7192721 Universal rapid test and method for detection of tuberculosis in multiple host species
US Patent 7192786 Biospecific assay method
US Patent 7195767 Method to detect IgE
US Patent 7211401 Method for the detection of prion diseases
US Patent 7220423 DNA immunization against
US Patent 7229615 Method for the purification, recovery, and sporulation of cysts and oocysts
US Patent 7232569 Type III secretion pathway in
US Patent 7238358 Compounds and methods for immunotherapy and diagnosis of tuberculosis
US Patent 7238359 Antigen ORF Rv2430c and a method thereof
US Patent 7244412 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
US Patent 7244838 Method for detecting, identifying and counting
US Patent 7261897 Fusion proteins of mycobacterium tuberculosis
US Patent 7264815 Process for producing a recombinant protein in a mycobacterium host plasmid pJAM2
US Patent 7273602 Immunotherapy for humans
US Patent 7276350 Method for diagnosing infectious diseases
US Patent 7279170 32-kDa protein derived from
US Patent 7288261 Mid-life vaccine and methods for boosting anti-mycobacterial immunity
US Patent 7291325 Method for producing target proteins by deleting or amplifying
US Patent 7297339 None
US Patent 7300660 Abundant extracellular products and methods for their production and use
US Patent 7311922 Fusion proteins of mycobacterium tuberculosis
US Patent 7320794 Transporter protein
US Patent 7323175 Immunogenicity of glucan binding protein
US Patent 7332340 Process for identifying a novel target for use for the development of therapeutic modalities and drugs effective against tuberculosis
US Patent 7332597 Primers and probe to identify mycobacterium tuberculosis complex
US Patent 7335369 Fusion proteins of
US Patent 7335480 Enriched antibody for detecting mycobacterial infection, methods of use and diagnostic test employing same
US Patent 7344703 Mycobacterial sulfation pathway proteins and methods of use thereof
US Patent 7344842 Prion test
US Patent 7361348 Immunogenic glycopeptides, screening, preparation and uses
US Patent 7387773 Vaccine
US Patent 7393539 Mycobacterial antigens expressed under low oxygen tension
US Patent 7393540 Mycobacterial antigens expressed during latency
US Patent 7413728 Immune modulator
US Patent 7413865 Diagnostic method for a transmissible spongiform encephalopathy or prion disease
US Patent 7417138 PNA chip for determining genotypes of mycobacterial species using plastic substrate coated with epoxy group-containing polymer and method of determining genotypes of mycobacterial species using the PNA chip
US Patent 7419788 Method for screening anti-bacterial agents
US Patent 7422869 Method for diagnosing infectious diseases
US Patent 7423008 Derivatives of mithramycin and methods of making and uses thereof
US Patent 7439040 Protease regulator screening assay
US Patent 7445895 Methods, kits and assay system for detecting drug-resistant
US Patent 7468190 Reduction in the virulence of
US Patent 7491395 Compositions comprising antigen-complexes, method of making same as well as methods of using the antigen-complexes for vaccination
US Patent 7501131 None
US Patent 7514088 Multivalent Clostridial toxin derivatives and methods of their use
US Patent 7521040 Immunotherapy for humans
US Patent 7527788 Desaturase antigen of Mycobacterium tuberculosis
US Patent 7531163 Enrichment methods for the detection of pathogens and other microbes
US Patent 7531164 Preventing bacterial or viral infectivity and composition containing infection preventing additive
US Patent 7534437 Helminth-derived antigens having capacity of providing protection against parasites
US Patent 7538206 Comparative mycobacterial geneomics as a tool for identifying targets for the diagnosis, prophylaxis or treatment of mycobacterioses
US Patent 7538208 Type III secretion pathway in
US Patent 7547506 Peptide-based fluorescence polarization assay for detection of antibodies to
US Patent 7556810 Compositions and methods to control angiogenesis with cupredoxins
US Patent 7566459 Modified mycobacterium tuberculosis strains and uses thereof
US Patent 7566543 Prion test
US Patent 7572457 Use of
US Patent 7572903 Method of regulation of bacterial persister status
US Patent 7575862 Assay systems, kits and methods for detecting microorganisms
US Patent 7575877 Method of diagnosing tuberculosis
US Patent 7579005 Process for recombinant expression and purification of antimicrobial peptides using periplasmic targeting signals as precipitable hydrophobic tags
US Patent 7579009 Whole bacterial cells as immune modulator
US Patent 7579012 Targeting of triacylglycerol synthase gene for tuberculosis treatment
US Patent 7579141 Proteins expressed by
US Patent 7579454 Method for detecting gram-positive bacteria
US Patent 7582304 Groups of
US Patent 7591997 Method for determining the susceptibility of a subject to infection
US Patent 7592135 High resolution typing system for pathogenic
US Patent 7595383 Secreted proteins of
US Patent 7597891 Synthesis of human secretory IgA for the treatment of
US Patent 7597893 Human monoclonal antibody specific lipopolysaccharides (LPS) of serotype IATS 06 of
US Patent 7597896 Composition comprising a protein encoded by a modified ERP gene of
US Patent 7601350 Antibodies that bind
US Patent 7601357 Targeting of long chain triacylglycerol hydrolase gene for tuberculosis treatment
US Patent 7601358 None
US Patent 7601831 Methods, kits and assay system for detecting drug-resistant
US Patent 7604953 Bioamplification for microbial sensor signal transduction
US Patent 7605248 Recombinant constructs of
US Patent 7608245 Methods for manipulating satiety
US Patent 7608246 Apolipoprotein E as an adjuvant for lipid antigens
US Patent 7608247 Use of outer membrane protein a in treatment/prevention/diagnosis of bacterial infection in central nervous system and/or peripheral blood circulation
US Patent 7608256 Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response
US Patent 7608277 Tuberculosis nucleic acids, polypeptides and immunogenic compositions
US Patent 7608278 Formulations of hydrophobic proteins in an immunogenic composition having improved tolerability
US Patent 7611720 Tuberculosis vaccines including recombinant BCG strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase
US Patent 7615207 Methods for treating irritable bowel syndrome
US Patent 7615222 Enriched antibody for detecting mycobacterial infection, methods of use and diagnostic test employing same
US Patent 7622128 None
US Patent 7625572 Transformed bacterium lacking selectable marker and overexpression of antigens in mycobacteria
US Patent 7635486 Recombinant lipidated PsaA protein, methods of preparation and use
US Patent 7638133 Recombinant BCG vaccine
US Patent 7638271 Use of antibody from lymphocyte secretions to diagnose active infection
US Patent 7638309 Method for detecting pathogenic mycobacteria in clinical specimens
US Patent 7642084 Assay systems, kits and methods for detecting microorganisms
US Patent 7655216 Vaccine for activating helper function of CD8
US Patent 7655784 Trans-sialidases obtained from
US Patent 7658922 Monoclonal antibodies, hybridoma cell lines, methods and kits for detecting phytase
US Patent 7658929 Immunogenic glycopeptides, screening, preparation and uses
US Patent 7659090 Methods for the separation of
US Patent 7670609 Recombinant BCG tuberculosis vaccine designed to elicit immune responses to
US Patent 7670610 Recombinant BCG vaccine
US Patent 7670824 Multicopy-integration of heterologous genes and expression in
US Patent 7674465 Regulation of gene expression by the
US Patent 7678375 Fusion proteins of
US Patent 7682796 Compositions and methods for detection, prevention, and treatment of anthrax and other infectious diseases
US Patent 7691373 Isolated mammalian membrane proteins; related agents
US Patent 7691383 Cupredoxin derived transport agents and methods of use thereof
US Patent 7691384 Method to detect IgE
US Patent 7691993 Fusion proteins of
US Patent 7695725 Modified free-living microbes, vaccine compositions and methods of use thereof
US Patent 7700109 Biomolecule transduction motif Mph-1-BTM and the use thereof
US Patent 7700118 Molecular differences between species of the
US Patent 7700298 Methods for determination of an analyte
US Patent 7700754 Polypeptide for unstabilizing protein in cells under aerobic conditions and DNA encoding the same
US Patent 7704685 In vivo production of a clostridial neurotoxin light chain peptide
US Patent 7709211 Proteins expressed by
US Patent 7709260 Sealing closure of bacterial ghosts by means of bioaffinity interactions
US Patent 7709622 Outer membrane protein of
US Patent 7722861 Attenuated
US Patent 7727711 Antibodies specific to antigens of
US Patent 7731937 Diagnostic method for paratuberculosis
US Patent 7731939 Vaccine compositions and adjuvant
US Patent 7732589 Primers for amplifying hsp 65 gene of mycobacterial species, hsp 65 gene fragments and method of identifying mycobacterial species with the same
US Patent 7736622 Methods of diagnosing small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US Patent 7736660 Roundworm coproantigen detection
US Patent 7740867 Method for identification of virulence determinants
US Patent 7744905 Immunogenic polypeptide isolated from mycobacterium avium subspecies paratuberculosis and uses thereof
US Patent 7744906 Pain relief agents
US Patent 7745141 Mycobacterial proteins as early antigens for serodiagnosis and vaccines
US Patent 7749501 Engineered antibody-stress protein fusions
US Patent 7749520 Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids
US Patent 7749696 Method and kit for the specific detection of
US Patent 7758869 Immunogenic compositions
US Patent 7758874 Attenuated
US Patent 7758875 Vaccine
US Patent 7763420 Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
US Patent 7772386 Identification of specific differentially expressed antigens
US Patent 7776341 Biomarkers of tuberculosis that distinguish disease categories: use as serodiagnostic antigens
US Patent 7780951 Vaccines for immunization against
US Patent 7785570 Combination vaccine for poultry
US Patent 7785571 Treatment of fungal infections
US Patent 7785597 VMP-like sequences of pathogenic
US Patent 7790143 Vaccines for immunization against helicobacter
US Patent 7794721 Synthesis of human secretory IgM and the treatment of clostridium difficile associated diseases herewith
US Patent 7803386 Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli
US Patent 7807139 Use of outer membrane protein A (OMPA) in treatment/prevention/diagnosis of infections caused by
US Patent 7807182 Early detection of mycobacterial disease using peptides
US Patent 7807183 Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof
US Patent 7807810 Nucleic acids encoding the major outer membrane protein of the causative agent of human granulocytic ehrlichiosis and peptides encoded thereby
US Patent 7811584 Multivalent clostridial toxins
US Patent 7811588 Mycobacterial genes down-regulated during latency
US Patent 7815896 Type III secretion pathway in
US Patent 7820184 Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
US Patent 7829103 Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation method and immunogenic compositions comprising same
US Patent 7829104 Electroporation of
US Patent 7833534 Compounds and methods for diagnosis and treatment of leishmaniasis
US Patent 7833699 Detection of tuberculosis and infection by
US Patent 7838013 Specific epitope based immunological diagnosis of tuberculosis
US Patent 7838018 Adjuvant combinations for immunization composition and vaccines
US Patent 7846420 None
US Patent 7846435 Humanized antibodies that recognize Verotoxin II and cell line producing same
US Patent 7847084 VMP-like sequences of pathogenic
US Patent 7850979 Compositions for immunizing against mycobacterium
US Patent 7851610 Transporter protein
US Patent 7858073 Oral killed vaccines and method for providing same
US Patent 7858093 Controlled-release immunogenic formulations to modulate immune response
US Patent 7863434 Characterization of granulocytic
US Patent 7867502 Tuberculosis vaccine and diagnostics based on the
US Patent 7867704 Mycobacterial diagnostics
US Patent 7867715 Method of evaluating the immunological activity of a vaccine
US Patent 7875259 Biological materials and methods useful in the diagnosis and treatment of diseases
US Patent 7879340 Treatment of mammalian reaction of IgE interactions
US Patent 7883696 Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response
US Patent 7883712 Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of
US Patent 7888037 Diagnostic kit for detecting pulmonary and extra pulmonary tuberculosis
US Patent 7888039 Assay for transmissible spongiform encephalopathies
US Patent 7888490 Process for the preparation of non-toxic anthrax vaccine
US Patent 7888491 Outer membrane protein of
US Patent 7893237 None
US Patent 7901689 Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies
US Patent 7902350 Method for monitoring the efficacy of a
US Patent 7906123 Modified
US Patent 7906277 Compound and methods for diagnosis of tuberculosis
US Patent 7919258 Rapid tuberculosis detection method
US Patent 7923001 Compositions and methods for diagnosing and treating urinary tract infections
US Patent 7927606 Modified free-living microbes, vaccine compositions and methods of use thereof
US Patent 7927609 Compounds and methods for immunotherapy and diagnosis of tuberculosis
US Patent 7927858 Drying process
US Patent 7928215 Methods of screening for compounds that inhibit the biosynthesis of GPI in malaria parasites
US Patent 7932373 Proteins expressed by mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines
US Patent 7935354 Generation of new BCG vaccine strains protecting against the establishment of latent
US Patent 7935804 Engineered
US Patent 7939089 Attenuated mycobacteria as vectors for gene delivery to mammalian cells
US Patent 7939650 Stra6 polypeptides
US Patent 7943133 Mesothelin antibody protein fusions and methods of use
US Patent 7943137 FPRL1 ligands and use thereof
US Patent 7947289 Multimeric protein toxins to target cells having multiple identifying characteristics
US Patent 7960535 Recombinant lipidated PsaA protein, methods of preparation and use
US Patent 7968105 Tuberculosis vaccines comprising antigens expressed during the latent infection phase
US Patent 7968694 Tuberculosis antigen detection assays and vaccines
US Patent 7973153 Fusion proteins of mycobacterium tuberculosis
US Patent 7976844 Fusion proteins of
US Patent 7976851 Non-toxic biofilm inhibitor
US Patent 7982025 Fusion proteins of
US Patent 7988980 Tuberculosis vaccine with improved efficacy
US Patent 7989605 Compounds and methods for immunotherapy and diagnosis of tuberculosis
US Patent 7993650 Polypeptides having binding affinity for HER2
US Patent 7993657 Antibody profiles characteristic of tuberculosis state
US Patent 7993658 Targeting of triacylclycerol synthase gene for tuberculosis treatment
US Patent 7998461 None
US Patent 7998471 Mycobacteria expressing HIV-1 and malaria antigens
US Patent 8003776 Mycobacterial antigens expressed during latency
US Patent 8012492 In vitro model of latent mycobacterial infection
Edits on 13 Dec, 2021
Golden AI
edited on 13 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 8012492 In vitro model of latent mycobacterial infection
Edits on 8 Dec, 2021
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 8003776 Mycobacterial antigens expressed during latency
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7998471 Mycobacteria expressing HIV-1 and malaria antigens
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7998461 None
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7993658 Targeting of triacylclycerol synthase gene for tuberculosis treatment
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7993657 Antibody profiles characteristic of tuberculosis state
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7993650 Polypeptides having binding affinity for HER2
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7989605 Compounds and methods for immunotherapy and diagnosis of tuberculosis
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7988980 Tuberculosis vaccine with improved efficacy
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7982025 Fusion proteins of
Edits on 8 Dec, 2021
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7976851 Non-toxic biofilm inhibitor
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7976844 Fusion proteins of
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7973153 Fusion proteins of mycobacterium tuberculosis
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7968694 Tuberculosis antigen detection assays and vaccines
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7968105 Tuberculosis vaccines comprising antigens expressed during the latent infection phase
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7960535 Recombinant lipidated PsaA protein, methods of preparation and use
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7947289 Multimeric protein toxins to target cells having multiple identifying characteristics
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7943137 FPRL1 ligands and use thereof
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7943133 Mesothelin antibody protein fusions and methods of use
Load more
Find more people like Rodney P Swartz
Use the Golden Query Tool to discover related individuals, professionals, or experts with similar interests, expertise, or connections in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE